AT&T Inc. continues to see a 'very healthy' wireless industry with no more promotional activity than what was observed in the holiday quarter.
AT&T Inc. continues to see a “very healthy” wireless industry with no more promotional activity than what was observed in the holiday quarter.
While the wireless environment is “not at the elevated pace that we saw in the early days of pandemic,” AT&T T Chief Financial Officer Pascal Desroches said at a Deutsche Bank investor conference Monday, it’s “still really healthy.” One compelling growth avenue in the wireless market these days comes as more people get second phones, Desroches suggested. Employers see security benefits to giving workers dedicated devices for company business, and workers want personal phones that give them flexibility from corporate restrictions.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Merck's Big Upgrade: 4 Big Analyst Calls | Pro Recap | Investing.comStocks Analysis by Garrett Cook covering: Alcoa Corp, Merck & Company Inc, Wingstop Inc, Dun And Bradstreet Holding Inc. Read Garrett Cook's latest article on Investing.com
Leer más »
Disinformation Inc: Government-backed group tried to punish sites boosting COVID lab leak theoryThis is part of a Washington Examiner series on self-styled 'disinformation' tracking groups that are blacklisting and trying to defund conservative media. Here is where you can read other stories in the series.
Leer más »
Pfizer eyes takeover of biotech Seagen, at value of more than $30 billionPfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed...
Leer más »
Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJPfizer Inc is in early talks to acquire drugmaker Seagen Inc , the Wall Street Journal reported late on Sunday, citing people familiar with the matter.
Leer más »
Pfizer in talks to buy cancer drugmaker Seagen - WSJPfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, the Wall Street Journal reported on Sunday, citing people familiar with the matter.
Leer más »
Warner Bros. Discovery sues Paramount over $500 million 'South Park' dealWarner Bros. Discovery Inc. is suing Paramount Global, saying its competitor aired new episodes of the popular animated comedy series “South Park” after...
Leer más »